RLAY - Balance Sheet - Relay Therapeutics, Inc.

Current Liabilities	50.7 M
Accounts Payable	14.1 M
Short-Term Debt	5.73 M
Other Current Liabilities	30.9 M
Non-Current Liabilities	42.8 M
Long-Term Debt	0
Other Non-Current Liabilities	42.8 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	124.3	143.7	998.9	958.1	447.6	42.0	421.5
Short Term Investments	657.0	606.4	847.1	678.0	230.4	313.9	0
Receivables	0	0	5.2	4.9	82.7	0	0
Inventory	0	0	12.1	(682.5)	(238.1)	0	0
Other Current Assets	27.9	20.0	15.4	13.2	9.4	4.7	2.6
Total Current Assets	809.2	770.1	1 019.5	976.2	770.1	360.5	424.1
PP&E	57.7	68.9	75.4	27.3	28.8	31.7	3.6
Intangible Assets	2.3	2.3	2.3	2.3	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	2.6	2.6	0.9	0.9	0.9
Other Long Term Assets	2.1	2.7	2.6	2.6	22 K	0	0
Other Assets	0	0	0	0	0	0	0
Total Assets	871.3	844.0	1 099.8	1 008.4	799.8	393.1	428.6
LIABILITIES
Accounts Payable	14.1	9.2	10.6	8.3	6.4	7.0	4.7
Short Term Debt	5.7	5.0	8.6	3.7	3.0	1.2	0.2
Other Current Liabilities	23.2	16.1	44.6	12.1	4.2	3.7	2.0
Total Current Liabilities	50.7	30.3	63.7	24.3	13.6	12.0	6.9
Long Term Debt	0	48.5	53.5	21.1	22.9	23.6	0
Deferred Tax Income	0	0	0	0	0	0	0
Other Liabilities	0	13.2	32.4	65.3	3 K	537.9	532.7
Total Liabilities	93.5	92.0	149.6	110.6	36.5	573.5	539.5
EQUITY
Common Stock	0.2	0.1	0.1	0.1	90 K	4 K	3 K
Retained Earnings	(1 738.3)	(1 400.6)	(1 058.6)	(768.1)	(404.2)	(189.5)	(114.2)
Other Accumulative Comprehensive Income/Loss	(1.0)	(0.2)	(10.4)	(1.1)	64 K	0.3	(4.6)
Total Equity	777.8	752.0	950.2	897.8	763.3	(180.4)	(110.9)
Total Liabilities and Equity	871.3	844.0	1 099.8	1 008.4	799.8	393.1	428.6
SHARES OUTSTANDING
Common Shares Outstanding	142.9	122.6	112.2	95.1	42.6	4.3	2.5

Free